Macasasa, Arlene S.
HRN: 26-91-50 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/10/2025
08/16/2025
IV
600mg
Q8
Infected Wound
Checking Initial Appropriateness
08/10/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/10/2025
08/16/2025
IV
1.5g
Q8
Infected Wound
Checking Initial Appropriateness
08/13/2025
CEFTAZIDIME 1GM (VIAL)
08/13/2025
08/20/2025
IV
2 Gram
OD
Infected Wound
Checking Initial Appropriateness
08/15/2025
CEFTRIAXONE 1G (VIAL)
08/15/2025
08/21/2025
IV
2gm
OD
Infected Wound
Checking Initial Appropriateness
08/21/2025
CEFTRIAXONE 1G (VIAL)
08/21/2025
09/04/2025
IVTT
2g
OD
Infected Wound
Checking Initial Appropriateness
08/25/2025
MUPIROCIN 2%, 15G (TUBE)
08/25/2025
08/31/2025
TOPICAL
2g
Twice A Day
Infected Wound Left Foot
Checking Initial Appropriateness